0001209191-21-006106.txt : 20210129
0001209191-21-006106.hdr.sgml : 20210129
20210129163229
ACCESSION NUMBER: 0001209191-21-006106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210128
FILED AS OF DATE: 20210129
DATE AS OF CHANGE: 20210129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nabulsi Azmi
CENTRAL INDEX KEY: 0001791412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39094
FILM NUMBER: 21571655
MAIL ADDRESS:
STREET 1: C/O PHATHOM PHARMACEUTICALS, INC.
STREET 2: 2150 E. LAKE COOK ROAD, SUITE 800
CITY: BUFFALO GROVE
STATE: IL
ZIP: 60089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001783183
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824151574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (877) 742-8466
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-28
0
0001783183
Phathom Pharmaceuticals, Inc.
PHAT
0001791412
Nabulsi Azmi
C/O PHATHOM PHARMACEUTICALS, INC.
100 CAMPUS DRIVE, SUITE 102
FLORHAM PAK
NJ
07932
0
1
0
0
Chief Operating Officer
Stock Option (Right to Buy)
39.11
2021-01-28
4
A
0
150000
0.00
A
2031-01-27
Common stock
150000
150000
D
The stock option will vest with respect to 25% of the shares of common stock on January 28, 2022, and will vest with respect to the remaining
shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the
applicable vesting dates.
/s/ Larry Miller, Attorney-in-Fact for Azmi Nabulsi
2021-01-29